Explore the categories so you can find more about your search.

Categorie > Bipolar

Alcohol Dependence May Respond To Aripiprazole, Treatment For Bipolar Disorder And Schizophrenia.

Categorie : Bipolar
* Aripiprazole is currently approved to treat bipolar disorder as well as schizophrenia. * A new study has found that it significantly and dose-dependently increases the sedative effects of alcohol and, to a lesser degree, decreases the euphoric effects of alcohol. * Future research will n ...

read more * Aripiprazole is currently approved to treat bipolar disorder as well as schizophrenia. * A new study has found that it significantly and dose-dependently increases the sedative effects of alcohol and, to a lesser degree, decreases the euphoric effects of alcohol. * Future research will n read more Sat Apr 2008 Sat Apr 2008

Famous Bipolar People Contest Raises Awareness, Encourages Research

Categorie : Bipolar
Famous bipolar people include some of the world's foremost musicians, actors, writers, composers and scientists. A new contest launched on YouTube uses the current interest in bipolar celebrities to raise awareness about bipolar disorder. The Famous Bipolar People Contest encourages research and ref ...

read more Famous bipolar people include some of the world's foremost musicians, actors, writers, composers and scientists. A new contest launched on YouTube uses the current interest in bipolar celebrities to raise awareness about bipolar disorder. The Famous Bipolar People Contest encourages research and ref read more Sat Apr 2008 Sat Apr 2008

Supplemental New Drug Application For RISPERDAL(R) CONSTA(R) Submitted To The FDA For The Treatment Of Frequently Relapsing Bipolar Disorder

Categorie : Bipolar
Alkermes, Inc. (NASDAQ: ALKS) announced that its partner, Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), submitted a Supplemental New Drug Application (sNDA) for RISPERDAL® CONSTA® [(risperidone) Long-Acting Injection] to the U.S. Food and Drug Administration (FDA) seeking ...

read more Alkermes, Inc. (NASDAQ: ALKS) announced that its partner, Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), submitted a Supplemental New Drug Application (sNDA) for RISPERDAL® CONSTA® [(risperidone) Long-Acting Injection] to the U.S. Food and Drug Administration (FDA) seeking read more Sat Apr 2008 Sat Apr 2008

AstraZeneca Announces First Presentation Of Pivotal SEROQUEL XR(TM) Bipolar Studies

Categorie : Bipolar
New pivotal trial data from two clinical studies with SEROQUEL XR? (quetiapine fumarate) once daily Extended Release Tablets were presented today at the Eighth International Review of Bipolar Disorder (IRBD) Conference in Copenhagen, Denmark. ...

read more New pivotal trial data from two clinical studies with SEROQUEL XR? (quetiapine fumarate) once daily Extended Release Tablets were presented today at the Eighth International Review of Bipolar Disorder (IRBD) Conference in Copenhagen, Denmark. read more Sat Apr 2008 Sat Apr 2008

European Marketing Authorization For Abilify - For Severe Manic Episodes In Bipolar I Disorder

Categorie : Bipolar
On April 8, 2008, the European Commission made a decision to allow thedrug ABILIFY® (aripiprazole) to be marketed. ABILIFY treats moderate tosevere manic episodes for patients with Bipolar I Disorder and it isdesigned to prevent new manic episodes in patients who experiencepredominately manic episod ...

read more On April 8, 2008, the European Commission made a decision to allow thedrug ABILIFY® (aripiprazole) to be marketed. ABILIFY treats moderate tosevere manic episodes for patients with Bipolar I Disorder and it isdesigned to prevent new manic episodes in patients who experiencepredominately manic episod read more Sat Apr 2008 Sat Apr 2008

Better Key Chains from Made in China.com

Categorie : Bipolar
Hot Key Chains Nowadays   Collecting key chains is one of the newest fashionable things to do nowadays. Both kids and adults are pursuing their favorite ones. Kids love key chains because the key chains can be shaped as their beloved fruit, animals, toys or even a ...

read more Hot Key Chains Nowadays   Collecting key chains is one of the newest fashionable things to do nowadays. Both kids and adults are pursuing their favorite ones. Kids love key chains because the key chains can be shaped as their beloved fruit, animals, toys or even a read more Thu Apr 2008 Thu Apr 2008

2008 Fashionable Handbags from Made in China.com

Categorie : Bipolar
Abstract: Handbags for 2008 are bigger and stronger. www.madeinchina.com has a great collection of handbags to suit all kinds of tastes. Canvas handbags are in with bright fruit colors; big shining leather handbags are still hot and we have varies kinds of styles to choose from. And ou ...

read more Abstract: Handbags for 2008 are bigger and stronger. www.madeinchina.com has a great collection of handbags to suit all kinds of tastes. Canvas handbags are in with bright fruit colors; big shining leather handbags are still hot and we have varies kinds of styles to choose from. And ou read more Thu Apr 2008 Thu Apr 2008

New Mouse Model Of Bipolar Disorder

Categorie : Bipolar
Bipolar Disorder (BPD or manic-depressive illness) is one of the most serious of all mental disorders, affecting millions of individuals worldwide. Affected individuals alternate between states of deep depression and mania. While depression is characterized by persistent and long-term sadness or des ...

read more Bipolar Disorder (BPD or manic-depressive illness) is one of the most serious of all mental disorders, affecting millions of individuals worldwide. Affected individuals alternate between states of deep depression and mania. While depression is characterized by persistent and long-term sadness or des read more Wed Mar 2008 Wed Mar 2008

New Clues For Uncovering The Mysteries Of Mental Illness

Categorie : Bipolar
Scientists have discovered epigenetic changes (i.e. chemical changes to a gene that do not alter the DNA sequence) in individuals with schizophrenia and bipolar disorder. This is the first epigenome-wide investigation in psychiatric research, and this groundbreaking data may be a significant step o ...

read more Scientists have discovered epigenetic changes (i.e. chemical changes to a gene that do not alter the DNA sequence) in individuals with schizophrenia and bipolar disorder. This is the first epigenome-wide investigation in psychiatric research, and this groundbreaking data may be a significant step o read more Wed Mar 2008 Wed Mar 2008

Breast Cancer Drug Tamoxifen May Decrease Mania Of Bipolar Disorder

Categorie : Bipolar
The drug tamoxifen is usually used to treat breast cancer, butresearchers say that it also may reduce symptoms of mania in peoplewith bipolar disorder. An article summarizing the small, three-weektrial of tamoxifen is published in Archives of GeneralPsychiatry.As a treatment for breast cancer, tamox ...

read more The drug tamoxifen is usually used to treat breast cancer, butresearchers say that it also may reduce symptoms of mania in peoplewith bipolar disorder. An article summarizing the small, three-weektrial of tamoxifen is published in Archives of GeneralPsychiatry.As a treatment for breast cancer, tamox read more Thu Mar 2008 Thu Mar 2008

ABILIFY Approved For Acute Treatment Of Bipolar I Disorder In Patients 10 To 17 Years Old

Categorie : Bipolar
Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company (NYSE: BMY) has announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application for ABILIFY® (aripiprazole) for the acute treatment of manic and mixed episodes associated with Bipolar I Disorde ...

read more Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company (NYSE: BMY) has announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application for ABILIFY® (aripiprazole) for the acute treatment of manic and mixed episodes associated with Bipolar I Disorde read more Tue Mar 2008 Tue Mar 2008

Indiana U Study May Alter Approach To Psychiatric Treatment

Categorie : Bipolar
Indiana University School of Medicine researchers have isolated biomarkers in the blood that identify mood disorders, a breakthrough that may change the way bipolar illness is diagnosed and treated. The report will be published in the February 26 advance online edition of the journal Molecular Psych ...

read more Indiana University School of Medicine researchers have isolated biomarkers in the blood that identify mood disorders, a breakthrough that may change the way bipolar illness is diagnosed and treated. The report will be published in the February 26 advance online edition of the journal Molecular Psych read more Fri Feb 2008 Fri Feb 2008

Alexza Initiates First Phase 3 Clinical Trial For AZ-004 (Staccato(R) Loxapine)

Categorie : Bipolar
Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced that it has initiated its first Phase 3 clinical trial with AZ-004 (Staccato(R) loxapine). AZ-004 is an inhalation product candidate being developed for the treatment of acute agitation in patients with schizophrenia or bipolar disorder. ...

read more Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced that it has initiated its first Phase 3 clinical trial with AZ-004 (Staccato(R) loxapine). AZ-004 is an inhalation product candidate being developed for the treatment of acute agitation in patients with schizophrenia or bipolar disorder. read more Fri Feb 2008 Fri Feb 2008

Bipolar Depression Licence Application For Seroquel(R)

Categorie : Bipolar
AstraZeneca has submitted an application to the Medicines and Healthcare products Regulatory Agency (MHRA) for a new licence for Seroquel(R) (quetiapine fumarate) in the UK for major depressive episodes in the framework of bipolar disorder. Quetiapine is currently licensed in the UK for the treatmen ...

read more AstraZeneca has submitted an application to the Medicines and Healthcare products Regulatory Agency (MHRA) for a new licence for Seroquel(R) (quetiapine fumarate) in the UK for major depressive episodes in the framework of bipolar disorder. Quetiapine is currently licensed in the UK for the treatmen read more Fri Feb 2008 Fri Feb 2008

Astrazeneca Submits Seroquel XR For The Treatment Of Bipolar Mania And Bipolar Depression, And Seroquel(R) For The Treatment Of Bipolar Depression

Categorie : Bipolar
AstraZeneca announced that the company has submitted applications in the European Union (EU) under the Mutual Recognition Procedure (MRP) for once-daily SEROQUEL XR(TM) (quetiapine fumarate) Extended-Release Tablets, seeking approval for the treatment of manic episodes associated with bipolar disord ...

read more AstraZeneca announced that the company has submitted applications in the European Union (EU) under the Mutual Recognition Procedure (MRP) for once-daily SEROQUEL XR(TM) (quetiapine fumarate) Extended-Release Tablets, seeking approval for the treatment of manic episodes associated with bipolar disord read more Tue Feb 2008 Tue Feb 2008

Study Suggests Risperidone Long-Acting Injection Combined With Standard Treatment Helped Delay Time To Relapse In Patients With Bipolar Disorder

Categorie : Bipolar
Patients with frequently relapsing bipolar disorder had a significant delay in the time to an initial relapse when risperidone long-acting injection (RLAI) was combined with standard treatment, according to a new study. The study compared patients who received RLAI and standard treatment to those w ...

read more Patients with frequently relapsing bipolar disorder had a significant delay in the time to an initial relapse when risperidone long-acting injection (RLAI) was combined with standard treatment, according to a new study. The study compared patients who received RLAI and standard treatment to those w read more Tue Feb 2008 Tue Feb 2008

ACADIA Announces Presentation Of Data On Pimavanserin Co-Therapy At The 14th Biennial Winter Workshop On On Schizophrenia And Bipolar Disorders

Categorie : Bipolar
ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that Murray Rosenthal, D.O. ...

read more ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that Murray Rosenthal, D.O. read more Tue Feb 2008 Tue Feb 2008

Scientists Discover Chemical Signature Of Manic Depression

Categorie : Bipolar
People with manic depression have a distinct chemical signature in their brains, according to a new study. The research, published in the journal Molecular Psychiatry, may also indicate how the mood stabilisers used to treat the disorder counteract the changes in the brain that it appears to cause. ...

read more People with manic depression have a distinct chemical signature in their brains, according to a new study. The research, published in the journal Molecular Psychiatry, may also indicate how the mood stabilisers used to treat the disorder counteract the changes in the brain that it appears to cause. read more Tue Feb 2008 Tue Feb 2008

Study Suggests Risperidone Long Acting Injection Combined With Standard Treatment Helped Delay Time To Relapse In Patients With Bipolar Disorder

Categorie : Bipolar
Patients with frequently relapsing bipolar disorder had a significant delay in the time to an initial relapse when risperidone long-acting injection (RLAI) was combined with standard treatment, according to a new study. The study compared patients who received RLAI and standard treatment to those w ...

read more Patients with frequently relapsing bipolar disorder had a significant delay in the time to an initial relapse when risperidone long-acting injection (RLAI) was combined with standard treatment, according to a new study. The study compared patients who received RLAI and standard treatment to those w read more Tue Feb 2008 Tue Feb 2008

Analysis of Chinese Engineering Machine Market in 2006 and Its Prediction in 2007

Categorie : Bipolar
1. China machine market review in 2007 In 2007 engineering machine state of business under national implementation macroeconomic regulation and control situation, and in the last few years the growth rate of China engineering machine is lowest between 2005 May to the end of ...

read more 1. China machine market review in 2007 In 2007 engineering machine state of business under national implementation macroeconomic regulation and control situation, and in the last few years the growth rate of China engineering machine is lowest between 2005 May to the end of read more Sat Feb 2008 Sat Feb 2008

1 | 2 | 3 | 4 next >>>